Vanguard Capital Management’s iSpecimen ISPC Stock Holding History
Bought
Maintained
Sold
Other funds holding ISPC
Vanguard Capital Management's ISPC Position: Q3 2026 in Review
Vanguard Capital Management sold out of iSpecimen (ISPC) in Q3 2026, closing a stake of 31 shares — an estimated $82 sold.
Vanguard Capital Management first reported a position in ISPC in Q1 2026 and held it in 2 quarters. The position peaked at $194 in Q1 2026. 9 funds tracked by Wall St. Rank hold ISPC as of Q3 2026.
- Vanguard Capital Management reported no remaining iSpecimen position as of Q3 2026 after selling out during the quarter.
- Vanguard Capital Management sold 31 iSpecimen shares in Q3 2026, an estimated $82.
- Vanguard Capital Management first reported a position in iSpecimen in Q1 2026 and held it in 2 quarters.
- Vanguard Capital Management's iSpecimen position peaked at $194 in Q1 2026.
- 9 funds tracked by Wall St. Rank held iSpecimen as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.